These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 29057980

  • 1. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
    Guerra FS, Oliveira RG, Fraga CAM, Mermelstein CDS, Fernandes PD.
    Sci Rep; 2017 Oct 20; 7(1):13723. PubMed ID: 29057980
    [Abstract] [Full Text] [Related]

  • 2. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
    Ogata S, Morishige K, Sawada K, Hashimoto K, Mabuchi S, Kawase C, Ooyagi C, Sakata M, Kimura T.
    Int J Gynecol Cancer; 2009 Dec 20; 19(9):1473-80. PubMed ID: 19955921
    [Abstract] [Full Text] [Related]

  • 3. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
    Zhang Z, Ren JH, Li ZY, Nong L, Wu G.
    Oncol Rep; 2012 May 20; 27(5):1561-6. PubMed ID: 22344855
    [Abstract] [Full Text] [Related]

  • 4. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
    Yang X, Liu Y, Zong Z, Tian D.
    Biomed Pharmacother; 2010 Jan 20; 64(1):58-62. PubMed ID: 19879105
    [Abstract] [Full Text] [Related]

  • 5. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L.
    Med Oncol; 2011 Jun 20; 28(2):565-71. PubMed ID: 20300976
    [Abstract] [Full Text] [Related]

  • 6. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R, Ohashi Y, Okada T, Kamata Y, Dinter H.
    Mol Cancer Ther; 2006 Sep 20; 5(9):2158-64. PubMed ID: 16985048
    [Abstract] [Full Text] [Related]

  • 7. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L, Li G, Li R, Liu Q, He Q, Zhang J.
    Cancer Biol Ther; 2010 Jun 01; 9(11):875-84. PubMed ID: 20364104
    [Abstract] [Full Text] [Related]

  • 8. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X, Di J, Zhang Y, Zhang S, Lu J, Liu J, Shi W.
    Biomed Pharmacother; 2012 Apr 01; 66(3):221-7. PubMed ID: 22425182
    [Abstract] [Full Text] [Related]

  • 9. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
    Yang X, Zhang Y, Wang S, Shi W.
    Can J Physiol Pharmacol; 2010 Sep 01; 88(9):874-9. PubMed ID: 20921973
    [Abstract] [Full Text] [Related]

  • 10. Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context.
    Matsubara M, Bissell MJ.
    Oncotarget; 2016 May 31; 7(22):31602-22. PubMed ID: 27203208
    [Abstract] [Full Text] [Related]

  • 11. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y, Cai X, Fan J, Zhang L, Li Z, Ren J, Wu G, Zhu F.
    Anticancer Drugs; 2017 Jun 31; 28(5):514-521. PubMed ID: 28225457
    [Abstract] [Full Text] [Related]

  • 12. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 13. KR-33028, a potent inhibitor of the Na+/H+ exchanger NHE1, suppresses metastatic potential of triple-negative breast cancer cells.
    Amith SR, Wilkinson JM, Fliegel L.
    Biochem Pharmacol; 2016 Oct 15; 118():31-39. PubMed ID: 27521504
    [Abstract] [Full Text] [Related]

  • 14. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
    Wu Q, Ma X, Jin Z, Ni R, Pan Y, Yang G.
    J Ethnopharmacol; 2023 Oct 28; 315():116644. PubMed ID: 37196814
    [Abstract] [Full Text] [Related]

  • 15. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY, Dun JN, Miao QF, Zhang YJ.
    Pharmacology; 2009 Oct 28; 83(2):67-79. PubMed ID: 19052484
    [Abstract] [Full Text] [Related]

  • 16. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
    Park JM, Han YM, Jeong M, Chung MH, Kwon CI, Ko KH, Hahm KB.
    Free Radic Biol Med; 2017 Sep 28; 110():151-161. PubMed ID: 28602912
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y, Zhang Q, Xi J, Xiao B, Li Y, Ma C.
    Int J Clin Exp Pathol; 2015 Sep 28; 8(3):2354-64. PubMed ID: 26045742
    [Abstract] [Full Text] [Related]

  • 18. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N.
    Oncotarget; 2016 Jul 12; 7(28):43124-43149. PubMed ID: 27281609
    [Abstract] [Full Text] [Related]

  • 19. Wnt-signaling mediates the anti-adipogenic action of lysophosphatidic acid through cross talking with the Rho/Rho associated kinase (ROCK) pathway.
    Li L, Tam L, Liu L, Jin T, Ng DS.
    Biochem Cell Biol; 2011 Dec 12; 89(6):515-21. PubMed ID: 21999426
    [Abstract] [Full Text] [Related]

  • 20. Fasudil hydrochloride could promote axonal growth through inhibiting the activity of ROCK.
    Xiao WD, Yu AX, Liu DL.
    Int J Clin Exp Pathol; 2014 Dec 12; 7(9):5564-8. PubMed ID: 25337198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.